Read this first. Affiliate commission does not influence editorial rank. Products without partnerships routinely outscore monetized ones — see our methodology for the literal scoring weights and our disclosure for full details on every commercial relationship.
Who we work with
Novo Nordisk, Eli Lilly, Pfizer, and other approved-drug sponsors.
Must hold valid telemedicine licenses in every state served and disclose PA support, refills, and refund terms.
Verifiable USP <797> compliance, valid state board licensure, sterile-injectable accreditation.
Pharmacogenomic, A1C, lipid panels — must publish lab partners and turnaround SLAs.
Third-party tested, NSF or USP-verified where applicable, no clinical claims without RCT support.
What we never accept
We turn down ~60% of inbound partnership inquiries. These are common reasons.
No FDA pathway, no GMP oversight, no safety data — we will not promote regardless of margin.
YMYL editorial standard requires transparent refund and prescription cancellation terms.
Anecdote and influencer testimonial are not evidence. We need RCT, observational data, or FDA filing.
Berberine, fiber blends, and similar are not GLP-1 analogs. We do not accept these placements at any rate.
Trial offers that auto-convert without clear opt-out are deceptive. We decline these regardless of commission.
Our 5-step partnership process
- 1Submit inquiry
Email [email protected] with product name, FDA status, evidence pack, and refund policy.
- 2Editorial vetting (5–10 business days)
We check clinical claims, regulatory status, and refund/cancellation terms against primary sources.
- 3Score independently
If accepted, product is scored on our 6-axis rubric. Affiliate status does not influence score.
- 4Commercial terms
Standard CPA or rev-share terms negotiated after editorial approval. We will not adjust scoring for higher commission.
- 5Quarterly re-review
Every featured partner is re-scored quarterly. FDA label changes or safety signals trigger immediate review.
Our editorial guarantees
Commission rate is not visible to the editor who scores your product. Sealed-envelope review.
Every clinical claim is checked against primary sources — FDA labeling and peer-reviewed studies — and linked inline before publication.
Errors are corrected within 5 business days and logged publicly. We do not silently retract.
If FDA flags your product post-publication, we de-rank within 24 hours. No commercial override available.
Submit your product for review
Email [email protected] with:
- · Product name, FDA approval status, and NDC code (if applicable)
- · Evidence pack: published clinical trials or FDA filings
- · Refund and cancellation policy (linkable)
- · List of states where you are licensed to operate
- · Commission terms (CPA, rev-share, hybrid)
- · Single point of contact for editorial questions
Response time: 5–10 business days. We review every submission but only accept ~40% of inbound inquiries.